Page last updated: 2024-08-21

1,4-androstadiene-3,17-dione and Prostatic Neoplasms

1,4-androstadiene-3,17-dione has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alves, JMP; Devendran, S; Erdman, JW; Hudson, ME; Ly, LK; Morris, DJ; Paul, HM; Ridlon, JM; Rowles, JL; Wolf, PM; Yemm, C1

Other Studies

1 other study(ies) available for 1,4-androstadiene-3,17-dione and Prostatic Neoplasms

ArticleYear
Bacterial steroid-17,20-desmolase is a taxonomically rare enzymatic pathway that converts prednisone to 1,4-androstanediene-3,11,17-trione, a metabolite that causes proliferation of prostate cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2020, Volume: 199

    Topics: Adrenal Glands; Androgens; Androstadienes; Cell Line, Tumor; Cell Proliferation; Clostridiales; Glucocorticoids; Humans; Hydrocortisone; Male; Metabolic Networks and Pathways; Phylogeny; Prednisolone; Prednisone; Propionibacteriaceae; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase

2020